J
Jade Biosciences, Inc. (JBIO)
NCM – Real Time Price. Currency in USD
13.39
-0.56 (-4.01%)
At close: Mar 27, 2026, 4:00 PM EDT
13.65
+0.26 (1.94%)
After-hours: Mar 27, 2026, 5:12 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
13.39
-0.56 (-4.01%)
At close: Mar 27, 2026, 4:00 PM EDT
13.65
+0.26 (1.94%)
After-hours: Mar 27, 2026, 5:12 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 21.09 | 6.05 | 10 | |
| Quick ratio | 21.09 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -68K | -96K | -282K | -26K | -26K |
| Operating Income | -53M | -81M | -75M | -114M | -94M |
| Net Income | -52M | -76M | -70M | -127M | -92M |
| EBITDA | -53M | -81M | -74M | -114M | -94M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 96.11 | 5.5 |
| Next quarter | N/A | 43.92 | 5.5 |
| Current year | N/A | 34.93 | 5.5 |
| Next year | N/A | -2.6 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -26.83 | 6.02 | -51.71 | 4.3 |
| Y/Y | 999 | -488.06 | 93.22 | -204.62 | 5.5 |
| 3y average | 999 | -40.58 | 29.23 | -34.35 | 5.5 |
| 5y average | 999 | -76.99 | 18.85 | -79.3 | 5.3 |
| Weighted average score | 5.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $88.4M significantly exceed its total debt $724.0K, ensuring strong financial flexibility
Total current assets $348.8M exceed Total current liabilities $16.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$33.7M limits the company's ability to reinvest or pay down debt